Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q8N6N7
UPID:
ACBD7_HUMAN
Alternative names:
-
Alternative UPACC:
Q8N6N7; A6NCI2; B3KTG8
Background:
Acyl-CoA-binding domain-containing protein 7 plays a crucial role in cellular metabolism by binding medium- and long-chain acyl-CoA esters. This interaction is pivotal for the regulation of intracellular lipid metabolism and energy production.
Therapeutic significance:
Understanding the role of Acyl-CoA-binding domain-containing protein 7 could open doors to potential therapeutic strategies. Its involvement in lipid metabolism suggests a possible link to metabolic disorders, offering a new avenue for research and drug development.